AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇪🇬
FUROSEMIDE 40 Mg ; in Egypt
10 products registered with EDA — 10 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Furosemide 40 mg / 4 ml USP 2025 Solution For I.M or I.V. Injection | UNKNOWN-956fdd6f | South Egypt Drug Industries Co (SEDICO) | active | — |
| Lasix ® Tablets | UNKNOWN-24405c25 | Sanofi Egypt | active | — |
| Lasiphar 40 mg /4 ml solution for I.M / slow IV injection or IV infusion | UNKNOWN-45f9ed95 | pharaonia pharmaceuticals (pharo pharma) | active | — |
| Furosemide 40 mg / 4 ml USP 2025 Solution For I.M or I.V. Injection | UNKNOWN-e7138201 | South Egypt Drug Industries Co (SEDICO) | active | — |
| Lasix ® Tablets | UNKNOWN-a0691eac | Sanofi Egypt | active | — |
| Lasiphar 40 mg /4 ml solution for I.M / slow IV injection or IV infusion | UNKNOWN-294959d9 | pharaonia pharmaceuticals (pharo pharma) | active | — |
| Lafurex ®40 mg /4ml solution for I.M / slow IV injection or IV infusion | UNKNOWN-ed103a6d | Amoun Pharmaceutical Company | active | — |
| Furosemide -Biocapital for Pharmaceutical & Chemical Industries sterile solution for IM , slow IV injection or infusion | UNKNOWN-2adfa5c5 | Biocapital for Pharmaceutical and Chemical Industries | active | — |
| Furosemide -Biocapital for Pharmaceutical & Chemical Industries sterile solution for IM , slow IV injection or infusion | UNKNOWN-a33ca8c2 | Biocapital for Pharmaceutical and Chemical Industries | active | — |
| Lafurex ®40 mg /4ml solution for I.M / slow IV injection or IV infusion | UNKNOWN-4171a5d9 | Amoun Pharmaceutical Company | active | — |
FUROSEMIDE 40 Mg ; — EDA Registration Details
EDA (Egypt) has 10 registered products containing FUROSEMIDE 40 Mg ;, of which 10 are currently active. Data is sourced directly from the official EDA drug register and refreshed daily.
Track FUROSEMIDE 40 Mg ; registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.